{"product_id":"advanced-nanovaccines-for-cancer-immunotherapy-nanasaheb-thorat-ebook","title":"Advanced Nanovaccines for Cancer Immunotherapy","description":"\u003cp\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003eChapter 1. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eAdvances in Cancer Vaccines: From Traditional Platforms to Nanotechnology\u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-IN; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003e \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eInnovations\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.- Chapter 2. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eCharacterization and Synthesis of Nanomaterial for Vaccine Delivery\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.- Chapter 3. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eNano-carriers for Cancer Nanovaccine\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.- Chapter 4. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eMechanism of Vaccine Development\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e. - Chapter 5. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eEngineering of Nanomaterials-based Cancer Nano-vaccine\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.- Chapter 6. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eAn Integrated Approach for Overcoming the Challenges Inherent in the Entire Vaccination Process for Tumor Immunotherapy Based on nanovaccines\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.- Chapter 7. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eClinical Applications of Nanovaccine\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.- Chapter 8. \u003c\/span\u003e\u003cspan lang=\"EN-US\" style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-fareast-font-family: 'Times New Roman'; color: black; mso-ansi-language: EN-US; mso-fareast-language: EN-IN; mso-bidi-language: AR-SA;\"\u003eCurrent Advances and Future Prospects of Advanced Nanotechnology in Cancer Immunotherapy\u003c\/span\u003e\u003cspan style=\"font-size: 11.0pt; line-height: 115%; font-family: 'Calibri','sans-serif'; mso-ascii-theme-font: minor-latin; mso-fareast-font-family: Calibri; mso-fareast-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-IN; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\"\u003e.\u003c\/span\u003e\u003c\/p\u003e","brand":"Nanasaheb Thorat","offers":[{"title":"Default Title","offer_id":53653339308359,"sku":"9783031861857","price":139.09,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0920\/5455\/2903\/files\/advanced-nanovaccines-for-cancer-immunotherapy-ebook-cover.webp?v=1775397801","url":"https:\/\/www.cinebuch.de\/products\/advanced-nanovaccines-for-cancer-immunotherapy-nanasaheb-thorat-ebook","provider":"CineBuch","version":"1.0","type":"link"}